Literature DB >> 26847050

Are abdominal aortic aneurysms with hostile neck really unsuitable for EVAR? Our experience.

Paolo Cerini1, Giuseppe Guzzardi2, Ignazio Divenuto2, Giuseppe Parziale2, Piero Brustia3, Alessandro Carriero2, Rita Fossaceca2.   

Abstract

OBJECTIVE: To evaluate the effectiveness of endovascular treatment of abdominal aortic aneurysms with hostile neck, comparing the results with those of patients with ideal anatomical conditions.
MATERIALS AND METHODS: From January 2005 to December 2013, 300 patients were treated with EVAR at our institution. Patients with a prior Angio-CT scan were included in the study and they were then retrospectively divided into two groups: patients with suitable anatomy that were treated within guidelines of the manufacturers (wIFU: 94 patients, four treated in emergency) and those with unsuitable anatomy that were treated outside of said guidelines (oIFU: 70 patients, 16 treated in emergency). Patients without prior CT study and without follow-up were excluded from the study.
RESULTS: Postoperative mortality was 6.3 % in the wIFU group while it was 7.8 % in the oIFU group. There was not a statistically significant difference in the rate of postoperative mortality (p = 0.653). Technical success was 98.6 % in the wIFU group while it was 94.5 % in the oIFU group. All the patients of the wIFU group were treated with a stent-graft with under-renal sealing while in the oIFU group always an over-renal stent-graft was used. No deaths related to the aneurysm were highlighted at follow-up in both groups. There was a statistically significative difference between the two groups regarding intraoperative occlusion of renal arteries (wIFU = 1.1 %; oIFU = 4.7 %; p < 0.05) and in the development of type I endoleak (wIFU = 2.8 %; oIFU = 8.8 %; p < 0.05)
CONCLUSION: EVAR in patients with hostile neck is feasible and effective with an acceptable rate of complications.

Entities:  

Keywords:  AAA; EVAR; Endoprosthesis; Endovascular treatment

Mesh:

Year:  2016        PMID: 26847050     DOI: 10.1007/s11547-016-0620-y

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  29 in total

1.  Letter by De Rango et al regarding article, "Predictors of abdominal aortic aneurysm sac enlargement after endovascular repair".

Authors:  Paola De Rango; Piergiorgio Cao; Fabio Verzini
Journal:  Circulation       Date:  2012-02-07       Impact factor: 29.690

2.  A single-centre experience of 200 consecutive unselected patients in percutaneous EVAR.

Authors:  Sergio Petronelli; Maria Teresa Zurlo; Silvia Giambersio; Lucia Danieli; Mariaelena Occhipinti
Journal:  Radiol Med       Date:  2014-04-04       Impact factor: 3.469

3.  Isolated iliac artery aneurysms: a single-centre experience.

Authors:  Rita Fossaceca; Giuseppe Guzzardi; Paolo Cerini; Ignazio Divenuto; Carmelo Stanca; Giuseppe Parziale; Piero Brustia; Alessandro Carriero
Journal:  Radiol Med       Date:  2014-10-28       Impact factor: 3.469

Review 4.  Endovascular abdominal aortic aneurysm repair in 144 patients: correlation of aneurysm size, proximal aortic neck length, and procedure-related complications.

Authors:  D M Hovsepian; A N Hein; T K Pilgram; D T Cohen; H S Kim; L A Sanchez; B G Rubin; D Picus; G A Sicard
Journal:  J Vasc Interv Radiol       Date:  2001-12       Impact factor: 3.464

5.  EVAR deployment in anatomically challenging necks outside the IFU.

Authors:  J T Lee; B W Ullery; C K Zarins; C Olcott; E J Harris; R L Dalman
Journal:  Eur J Vasc Endovasc Surg       Date:  2013-04-28       Impact factor: 7.069

6.  Evaluation of the Endurant stent graft under instructions for use vs off-label conditions for endovascular aortic aneurysm repair.

Authors:  Giovanni Torsello; Nicola Troisi; Konstantinos P Donas; Martin Austermann
Journal:  J Vasc Surg       Date:  2011-03-11       Impact factor: 4.268

7.  The AAA with a challenging neck: outcome of open versus endovascular repair with standard and fenestrated stent-grafts.

Authors:  Emiliano Chisci; Thorarinn Kristmundsson; Gianmarco de Donato; Timothy Resch; Francesco Setacci; Björn Sonesson; Carlo Setacci; Martin Malina
Journal:  J Endovasc Ther       Date:  2009-04       Impact factor: 3.487

8.  Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population.

Authors:  Marc L Schermerhorn; A James O'Malley; Ami Jhaveri; Philip Cotterill; Frank Pomposelli; Bruce E Landon
Journal:  N Engl J Med       Date:  2008-01-31       Impact factor: 91.245

9.  Outcomes following endovascular abdominal aortic aneurysm repair (EVAR): an anatomic and device-specific analysis.

Authors:  Thomas A Abbruzzese; Christopher J Kwolek; David C Brewster; Thomas K Chung; Jeanwan Kang; Mark F Conrad; Glenn M LaMuraglia; Richard P Cambria
Journal:  J Vasc Surg       Date:  2008-04-28       Impact factor: 4.268

10.  Endovascular abdominal aortic aneurysm repair and renal complications: a comparison between suprarenal and infrarenal fixation of stent grafts.

Authors:  A R Cotroneo; R Iezzi; D Giancristofaro; M Santoro; A Pierro; F Spigonardo; M L Storto
Journal:  Radiol Med       Date:  2007-03-19       Impact factor: 3.469

View more
  3 in total

1.  Ethylene-vinyl alcohol copolymer as embolic agent for treatment of type II endoleak: our experience.

Authors:  Anna Maria Ierardi; Camilla Micieli; Salvatore Alessio Angileri; Nicola Rivolta; Gabriele Piffaretti; Massimo Tonolini; Federico Fontana; Vittorio Miele; Luca Brunese; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2016-11-05       Impact factor: 3.469

Review 2.  Is Evar Feasible in Challenging Aortic Neck Anatomies? A Technical Review and Ethical Discussion.

Authors:  Pasqualino Sirignano; Silvia Ceruti; Francesco Aloisi; Ascanio Sirignano; Mario Picozzi; Maurizio Taurino
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

3.  A Statistical Shape Model of the Morphological Variation of the Infrarenal Abdominal Aortic Aneurysm Neck.

Authors:  Willemina A van Veldhuizen; Richte C L Schuurmann; Frank F A IJpma; Rogier H J Kropman; George A Antoniou; Jelmer M Wolterink; Jean-Paul P M de Vries
Journal:  J Clin Med       Date:  2022-03-18       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.